Home » Archive for March, 2013
Copyright Law Takes Aim At Google in Germany (NASDAQ:GOOG)
German lawmakers passed legislation that will limit search engines and online aggregators to only using a small amount of text from links and brief summaries without having to pay the publishers for the content. Publishers are asking companies like Google to share the profits it receives from advertisements placed beside the news it links to. The Free Democratic Party changed the bill at the last...
Love Blooms Amid Steamy Summer Savings at Saint Lucia’s Calabash Cove Resort & Spa
Take Advantage of this Romantic Beachfront Retreat’s Lowest Rates of the Year – Plus Early Booking Bonus Savings — and Enrich Your Relationship without Emptying Your Wallet.
St. Lucia, West Indies (3/28/2013): Embrace summer — and limited-time savings — with a getaway to Calabash Cove Resort & Spa, a beguiling beachfront boutique resort located on the Caribbean’s most...
Aastrom Biosciences PT Set at $3.00 by JMP Securities (ASTM)
Equities research analysts at JMP Securities set a $3.00 price target on shares of Aastrom Biosciences (NASDAQ: ASTM) stock in a research note issued to investors on Thursday, TheFlyOnTheWall.com reports. The firm currently has a a “market outperform” rating on the stock.
A number of other firms have also recently commented on ASTM. Analysts at Needham & Company downgraded shares of...
Ariad Pharmaceutical Coverage Initiated at Goldman Sachs (ARIA)
Equities researchers at Goldman Sachs assumed coverage on shares of Ariad Pharmaceutical (NASDAQ: ARIA) in a report issued on Thursday, TheFlyOnTheWall.com reports. The firm set a “neutral” rating on the stock.
The analysts wrote, “ARIA is building a fully integrated, global biopharma company focused on targeted cancer therapies. The company obtained US regulatory approval of its...
Advanced Energy Industries Lowered to “Underperform” at Bank of America (AEIS)
Advanced Energy Industries (NASDAQ: AEIS) was downgraded by equities research analysts at Bank of America from a “neutral” rating to an “underperform” rating in a research note issued to investors on Thursday.
The analysts wrote, “We are downgrading AEIS from a Buy to Underperform rating. Following a strong rally (+39% YTD), the stock has exceeded our price objective...
Columbia Sportswear Now Covered by Goldman Sachs (COLM)
Investment analysts at Goldman Sachs began coverage on shares of Columbia Sportswear (NASDAQ: COLM) in a note issued to investors on Thursday. The firm set a “neutral” rating and a $60.00 price target on the stock.
The analysts wrote, “We resume coverage of COLM with a $60, six-month price target and Neutral rating relative to our Attractive coverage view. COLM’s focus and...
V.F. Receives New Coverage from Analysts at Goldman Sachs (VFC)
Analysts at Goldman Sachs started coverage on shares of V.F. (NYSE: VFC) in a research report issued to clients and investors on Thursday. The firm set a “buy” rating and a $200.00 price target on the stock.
The analysts wrote, “We resume coverage of VF Corp with a Buy rating and 21% upside potential to our $200, six-month price target. The story here is powerful brand stories executing...
Aegerion Pharmaceuticals Price Target Raised to $52.00 at Deutsche Bank (AEGR)
Research analysts at Deutsche Bank boosted their target price on shares of Aegerion Pharmaceuticals (NASDAQ: AEGR) from $41.00 to $52.00 in a report released on Thursday, TheFlyOnTheWall.com reports. The firm currently has a “buy” rating on the stock.
The analysts wrote, “AEGR has made assumptions for dropouts, which are key to their guidance of ending the year with 250-300 patients...
Ecolab Now Covered by Canaccord Genuity (ECL)
Investment analysts at Canaccord Genuity began coverage on shares of Ecolab (NYSE: ECL) in a note issued to investors on Thursday, TheFlyOnTheWall.com reports. The firm set a “buy” rating on the stock.
The analysts wrote, “Ecolab is a leading provider of advanced technologies and services helping to optimize the use of resources such as water, energy, food and the environment. We...
Emerson Electric Now Covered by Analysts at Canaccord Genuity (EMR)
Equities researchers at Canaccord Genuity assumed coverage on shares of Emerson Electric (NYSE: EMR) in a report issued on Thursday, TheFlyOnTheWall.com reports. The firm set a “hold” rating on the stock.
The analysts wrote, “While Emerson has benefitted from a rebound in macroeconomic activity, tougher growth compares and a focus on optimizing assets near term keep expectations...